Indicators of Quality of Life and Functional Status of Patients with Arterial Hypertension and Gout
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to evaluate the quality of life (QOL) and functional status of patients with arterial hypertension (AH) and gout, to determine the factors influencing the QOL in this category of patients.
Materials and methods. The study included 61 patients with AH, mean age (SD) of 54,25±10,29 years, which were divided into 2 groups: group 1 (n=36, main) –patients with AH and gout, group 2 (n=25, comparison) – patients with AH. The control group included 10 patients. The QOL was evaluated using the Short Form Medical Outcomes Study (SF-36) questionnaire, the Health Assessment Questionnaire (HAQ-DI) and the 10-point Patient Global Assessment (PGA).
Results. Patients with AH and gout were more likely to have lowered their physical health indicators and the role-emotional. The average value of the HAQ-DI questionnaire was significantly lower in the main group, and on the PGA scale, in the main and comparison group.
Conclusion. QOL of patients with AH and gout has been reduced to a greater extent in comparison with patients without gout due to chronic pain syndrome, functional constraints, psychological problems. Factors affecting the lung in this category of patients are the clinical manifestations of AH and gout: age, number of exacerbations of AH per year, total cardiovascular risk (TCVR), total number of affected joints, severity of gout, comorbidity.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Differences in behavior profile between normotensive subjects and patients with white-coat and sustained hypertension / R. Coelho, A. Santos, L. Ribero [et al.] // J. Psychosom. Res. – 2011. – V. 46. – P. 15–27.
Arterial Hypertension and Health-Related Quality of Life / V. Katsi, M.S. Kallistratos, К. Kontoangelos [et al.] // Front. Psychiatry. – 2017. – V. 8. – Р. 270.
Health-related quality of life of hypertension in China: a systematic review and meta-analysis / R. Ye, K. Liu, Z. Zhang [et al.] // J. Cardiovasc. Med. (Hagerstown). – 2018. – V. 19 (8). – Р. 430–438.
Health-related quality of life in gout in primary care: Baseline findings from a cohort study / P. Chandratre, C. Mallen, J. Richardson [et al.] // Semin. Arthritis Rheum. – 2018. – V. 48 (1). – P. 61–69.
Health-related quality of life in gout: a systematic review / P. Chandratre, E. Roddy, L. Clarson [et al.] // Rheumatology (Oxford). – 2013. – V. 52 (11). – P. 2031–2040.
Singh J.A. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans / J.A. Singh, V. Strand // Ann. Rheum. Dis. – 2008. – V. 67. – P. 1310–1316.
Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / G. Mancia, R. Fagard, K. Narkiewicz [et al.] // Journal of Hypertension. – 2013. – V. 31. – Р. 1281-1357.
Lilian H.D. van Tuyl. Patient’s Global Assessment of Disease Activity: What Are We Measuring? / van Tuyl H.D. Lilian, M. Boers // Arthritis and Rheumatism. – 2012. – V. 64 (9). – P. 2811–2813.
Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR) / C.A. Scirè, M. Manara, M.A. Cimmino [et al.] // Arthritis Res. Ther. – 2013. – V. 15 (5). – P. 101.
